Thromboangiitis obliterans:: A rare cause of a reversible Raynaud's phenomenon

被引:7
作者
Noël, B [1 ]
Krayenbühl, B [1 ]
Cerottini, JP [1 ]
Guggisberg, D [1 ]
Buxtorf, K [1 ]
Pires, A [1 ]
Panizzon, RG [1 ]
机构
[1] CHU Vaudois, DHURDV, Dept Dermatol, Serv Dermatovenereol, CH-1011 Lausanne, Switzerland
关键词
Raynaud's phenomenon; thromboangiitis obliterans; iloprost;
D O I
10.1159/000018412
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
A 25-year-old woman with progressive Raynaud's phenomenon and digital necrosis is presented. Systemic sclerosis and other connective tissue disorders as well as atherosclerosis and arterial emboli were excluded with appropriate laboratory examinations. Arteriography revealed multiple palmar and digital occlusions with corkscrew-shaped vessels. Based on these characteristic arteriographic and clinical findings, the diagnosis of thromboangiitis obliterans was finally retained, With intravenous perfusion of the prostacyclin analogue iloprost (2 ng/kg/min, 6 h daily during 21 days), a complete healing of Raynaud's phenomenon and of the digital necrosis was observed. There was no recurrence during the 1-year follow-up. This observation demonstrates that thromboangiitis obliterans is a potential reversible cause of severe Raynaud's phenomenon in young women even in the absence of lower limb involvement. Early recognition is important to avoid irreversible complications such as loss of digits. Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:363 / 365
页数:3
相关论文
共 22 条
  • [1] ORAL ILOPROST AS A TREATMENT FOR RAYNAUDS SYNDROME - A DOUBLE-BLIND MULTICENTER PLACEBO-CONTROLLED STUDY
    BELCH, JJF
    CAPELL, HA
    COOKE, ED
    KIRBY, JDT
    LAU, CS
    MADHOK, R
    MURPHY, E
    STEINBERG, M
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1995, 54 (03) : 197 - 200
  • [2] Biasi D, 1998, REV RHUM, V65, P745
  • [3] Cerebral vein thrombosis in a case with thromboangiitis obliterans
    Bischof, F
    Kuntz, R
    Melms, A
    Fetter, M
    [J]. CEREBROVASCULAR DISEASES, 1999, 9 (05) : 295 - 297
  • [4] Black CM, 1998, BRIT J RHEUMATOL, V37, P952
  • [5] Borner C, 1998, VASA-J VASCULAR DIS, V27, P80
  • [6] CASPARY L, 1991, EUR J CLIN PHARMACOL, V41, P131
  • [7] Disdier P, 1999, PRESSE MED, V28, P71
  • [8] TRIAL OF ILOPROST VERSUS ASPIRIN TREATMENT FOR CRITICAL LIMB ISCHEMIA OF THROMBOANGIITIS-OBLITERANS
    FIESSINGER, JN
    SCHAFER, M
    [J]. LANCET, 1990, 335 (8689) : 555 - 557
  • [9] ILOPROST - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN PERIPHERAL VASCULAR-DISEASE, MYOCARDIAL-ISCHEMIA AND EXTRACORPOREAL-CIRCULATION PROCEDURES
    GRANT, SM
    GOA, KL
    [J]. DRUGS, 1992, 43 (06) : 889 - 924
  • [10] THORACOSCOPIC SYMPATHECTOMY FOR BUERGERS-DISEASE - A REPORT ON THE SUCCESSFUL TREATMENT OF 4 PATIENTS
    ISHIBASHI, H
    HAYAKAWA, N
    YAMAMOTO, H
    NISHIKIMI, N
    YANO, T
    NIMURA, Y
    [J]. SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 1995, 25 (02): : 180 - 183